Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin
Status:
Completed
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
The drug-drug interaction study had been designed to investigate the effect of Leritrelvir on
the pharmacokinetics of Midazolam, Omeprazole, Rosuvastatin and the effect of Verapamil and
Rifampin on the pharmacokinetics of Leritrelvir